BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29946934)

  • 1. [Prophylactic vaccination against HP viruses for the prevention of cervical cancer : Implementation of gender neutral, prophylactic vaccination in Germany as an effective instrument for prevention].
    Huck N
    Urologe A; 2018 Jul; 57(7):850-851. PubMed ID: 29946934
    [No Abstract]   [Full Text] [Related]  

  • 2. [How does it go on with the HPV vaccination?].
    Kaulen H
    Dtsch Med Wochenschr; 2007 Jan; 132(4):132. PubMed ID: 17338090
    [No Abstract]   [Full Text] [Related]  

  • 3. Cervical cancer and prevention by vaccination: results from recent trials.
    Tjalma WA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x217-23. PubMed ID: 17018727
    [No Abstract]   [Full Text] [Related]  

  • 4. Who should be vaccinated against human papillomavirus?
    Tjalma WA; van Damme P
    Int J Gynecol Cancer; 2006; 16(4):1498-9. PubMed ID: 16884357
    [No Abstract]   [Full Text] [Related]  

  • 5. Australian HPV vaccination programme yields results.
    Howe M
    Lancet Oncol; 2014 Dec; 15(13):e591. PubMed ID: 25499291
    [No Abstract]   [Full Text] [Related]  

  • 6. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipating full benefits from the new papillomavirus vaccines.
    Griffiths PD
    Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
    [No Abstract]   [Full Text] [Related]  

  • 10. [Papillomavirus, could we speak about cancer and prevention?].
    Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
    Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccination against human papilloma virus. Has cervical cancer been beaten?].
    Kimmig R
    MMW Fortschr Med; 2007 Mar; 149(12):28-9. PubMed ID: 17674886
    [No Abstract]   [Full Text] [Related]  

  • 12. Human papillomavirus vaccines and prevention of cervical cancer.
    Jansen KU; Shaw AR
    Annu Rev Med; 2004; 55():319-31. PubMed ID: 14746524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
    Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K; Reisinger K
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.
    Bogani G; Leone Roberti Maggiore U; Signorelli M; Martinelli F; Ditto A; Sabatucci I; Mosca L; Lorusso D; Raspagliesi F
    Crit Rev Oncol Hematol; 2018 Feb; 122():92-97. PubMed ID: 29458794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention.
    Garcia FA; Saslow D
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):761-81, ix. PubMed ID: 18061868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving our understanding of the prevention of human papillomavirus.
    Irwin CE; Berg TD
    J Adolesc Health; 2011 Nov; 49(5):449. PubMed ID: 22018556
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic vaccines for human papillomavirus: a bright future for cervical cancer prevention.
    Szarewski A
    J Med Screen; 2005; 12(4):163-5. PubMed ID: 16417690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.